Search Results

Bevacizumab: Portal venous gas in an elderly patient: case report

Source: Reactions, Volume 1, Number 1279, 2009-11-21 , pp. 10-11(2)

Publisher: Adis International

Bevacizumab/sunitinib withdrawal: Rebound subdural collections: 2 case reports

Source: Reactions, Volume 1, Number 1279, 2009-11-21 , pp. 11-11(1)

Publisher: Adis International

Bevacizumab: Progression of angioid streaks following intravitreal administration: case report

Source: Reactions, Volume 1, Number 1279, 2009-11-21 , pp. 11-11(1)

Publisher: Adis International

The Use of Bevacizumab and Trastuzumab Beyond Tumor Progression: A New Avenue in Cancer Treatment?

Authors: Meriggi, F.; Abeni, C.; Di Biasi, B.; Zaniboni, A.

Source: Reviews on Recent Clinical Trials, Volume 4, Number 3, September 2009 , pp. 163-167(5)

Publisher: Bentham Science Publishers

AE treatment cheaper with bevacizumab in lung/renal cancer

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 592, 2009-11-28 , pp. 6-6(1)

Publisher: Adis International

Chemotherapy and cardiac safety

Source: Reactions, Volume 1, Number 1280, 2009-11-28 , pp. 6-6(1)

Publisher: Adis International

Bevacizumab: Pulmonary hypertension: 2 case reports

Source: Reactions, Volume 1, Number 1280, 2009-11-28 , pp. 11-11(1)

Publisher: Adis International

Bevacizumab: Pneumatosis intestinalis in an elderly patient: case report

Source: Reactions, Volume 1, Number 1280, 2009-11-28 , pp. 11-11(1)

Publisher: Adis International

Bevacizumab: Epistaxis and hypertension: 3 case reports

Source: Reactions, Volume 1, Number 1277, 2009-11-07 , pp. 10-11(2)

Publisher: Adis International

Bevacizumab/paclitaxel: Fatal intestinal perforation: case report

Source: Reactions, Volume 1, Number 1277, 2009-11-07 , pp. 11-11(1)

Publisher: Adis International

Bevacizumab: Foveal vascular zone enlargement after intravitreal injection in a diabetic patient: case report

Source: Reactions, Volume 1, Number 1277, 2009-11-07 , pp. 11-11(1)

Publisher: Adis International

Bevacizumab: Intestinal perforation in an elderly patient: case report

Source: Reactions, Volume 1, Number 1277, 2009-11-07 , pp. 11-11(1)

Publisher: Adis International

Optimizing regional infusion treatment strategies for melanoma of the extremities

Authors: Coleman, Andrew; Augustine, Christina K; Beasley, Georgia; Sanders, Gretchen; Tyler, Douglas

Source: Expert Review of Anticancer Therapy, Volume 9, Number 11, November 2009 , pp. 1599-1609(11)

Publisher: Expert Reviews

Vascular endothelial growth factor and mTOR pathways in renal cell carcinoma: differences and synergies of two targeted mechanisms

Author: Mulders, Peter

Source: BJU International, Volume 104, Number 11, December 2009 , pp. 1585-1589(5)

Publisher: Blackwell Publishing

Gastric cancer drug market to grow through targeted therapies

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 591, 2009-11-14 , pp. 14-14(1)

Publisher: Adis International

Bevacizumab: Arterial hypertension: 2 case reports

Source: Reactions, Volume 1, Number 1278, 2009-11-14 , pp. 11-11(1)

Publisher: Adis International

Anti-angiogenic Therapy Against Gastrointestinal Tract Cancers

Authors: Iwasaki, Junko; Nihira, Shin-ichi

Source: Japanese Journal of Clinical Oncology, Volume 39, Number 9, 11 September 2009 , pp. 543-551(9)

Publisher: Oxford University Press

Erlotinib in non-small-cell lung cancer: a review of the clinical and economic evidence

Author: Carlson, Josh J

Source: Expert Review of Pharmacoeconomics and Outcomes Research, Volume 9, Number 5, October 2009 , pp. 409-416(8)

Publisher: Expert Reviews

Nearly one-fifth of eligible cancer patients in the US fail to receive Avastin [bevacizumab] due to its high cost

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 589, 2009-10-17 , pp. 8-8(1)

Publisher: Adis International

The breast cancer drug market in China is expected to grow from $165 million in 2008 to $298 million in 2013

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 589, 2009-10-17 , pp. 11-11(1)

Publisher: Adis International